Navigation Links
Study Suggests Soy Protein May Reduce Prostate Cancer Risk
Date:10/4/2007

ST. LOUIS, Oct. 4 /PRNewswire/ -- A study published in the Oct. 1 Journal of Nutrition suggests consumption of soy protein may play a role in reducing the risk of prostate cancer, Solae notes, giving consumers another healthy reason to make soy part of their diet.

The study, "Soy protein isolate increases urinary estrogens and the ratio of 2:16 alpha-hydroxyestrone in men at high risk of prostate cancer," is believed to be the first study investigating the effects of soy protein consumption on estrogen metabolism and prostate cancer in men.

"The intent of the study was to evaluate the effects of consuming soy protein on elimination of estrogen metabolites in the urine of men at a high risk for prostate cancer," said Dr. Mindy Kurzer, lead author of the study and a professor in the Department of Food Science and Nutrition at the University of Minnesota. "After taking biopsies of prostate tissue, androgen receptors were reduced in the prostate, which is consistent with a reduced risk of prostate cancer. In addition, significantly fewer of the men who consumed soy protein progressed to cancer by the end of the six-month study. We are encouraged by the results, but more studies must be performed."

"The results of this study could be beneficial for men who are at risk of prostate cancer," said Dr. Kathryn Greaves, Group Lead, Clinical Nutrition at Solae. "If the results of this study are replicated in future studies, reducing the risk of prostate cancer may be another reason to include soy in your daily diet."

Soy has been documented to potentially improve heart health and aid in sports performance and weight management. For more information on Solae and its products, please visit http://www.solae.com.

About Solae

Solae is the world leader in developing innovative soy-based technology to the food, meat and nutritional products industries. Solae provides solutions that deliver a un
'/>"/>

SOURCE Solae
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... , CHICAGO and STAFA, Switzerland, Nov. 25 /PRN...ing manufacturer of innovative hearing solutions, ...or Adults Conference, focusing on the special need...together leading experts in aging and audiology fr...ho work everyday with older people with hearing lo...
(Date:11/25/2009)... , COLLEGE PARK, Md., Nov. 25 /PRNewswire-USN...developing a shaving cream-like foam that stops se...Most Promising Security Idea category of the Globa...nce today. ,, Selected from more than 100 entri...their invention at the GSC Security Summit confere...
(Date:11/25/2009)... , NEW YORK, Nov. 25 Repo...report is available in its catalogue: ,, Unite...sts to 2015 ,, http://www.reportlinker.com/p0...s-and-Forecasts-to-2015.html ,, United States ...15 ,, Summary ,, This report is an essenti...
Breaking Medicine Technology:Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 13Cytox Raises Pre Series A Financing From Management and Existing UK Investors Welcomes First US Investors 49846 1Cytox Raises Pre Series A Financing From Management and Existing UK Investors Welcomes First US Investors 49846 2Cytox Raises Pre Series A Financing From Management and Existing UK Investors Welcomes First US Investors 49846 3Cytox Raises Pre Series A Financing From Management and Existing UK Investors Welcomes First US Investors 49846 4M2SYS Technology to Offer Desktop Biometric Technology to Kronos Customers 8975 1M2SYS Technology to Offer Desktop Biometric Technology to Kronos Customers 8975 2Bariatric Surgery Cuts Cancer Risk for Women 49841 1Bariatric Surgery Cuts Cancer Risk for Women 49841 2Bariatric Surgery Cuts Cancer Risk for Women 49841 3
...K, Md., July 29 ImQuest BioSciences announced,tod...National Institute of,Allergy and Infectious Disea...idinedione inhibitors as topical microbicides to p...r Small Business Innovative Research (SBIR),grant ...the dual-acting,pyrimidinedione molecules which ef...
... TRIANGLE PARK, N.C., July 27 Timothy Mastro,MD, ... (FHI) on August 1st,as Senior Director of Researc...to pre-exposure prophylaxis (PrEP) for HIV prevent... City., Dr. Mastro,s presentation, titled "Pre-Ex...ill examine ongoing and upcoming clinical trials t...
Other Medicine Technology:ImQuest Receives Two Year Phase 2 SBIR Grant to Develop Pyrimidinedione Product as an Anti-HIV Topical Microbicide 2HIV Prevention Expert Dr. Timothy Mastro Speaks on Future of Pre-Exposure Prophylaxis at International AIDS Conference 2
(Date:11/26/2009)... Dental (RTDental), a leading dental group practic...xpansion of its services to include LUMINEERS by a... , Durham, NC (PRWEB) --...hat Dr. Doug Macmillan, an experienced LUMINEERS ...d training seminar. RTDental’s ability to f...
(Date:11/25/2009)...re-USNewswire/ -- When most people hear the acrony...actor can also give patients the help they need. T... is where your jaw (mandible) contacts/connects wi...mon symptoms associated with TMJ dysfunction are p... But many other symptoms can be caused from TMJ dy...
(Date:11/25/2009).../-SentinelleMedicalInc.,aleadingmanufacturerofMagn...yScientificInc.,aleadingproviderofsoftwareenabling...reast4DAdvancedVisualizationsoftware. ,, Thisin...lientbasedmedicalimagingofferinginthemarket.Calgar...printaccess-requiringnosoftwaredownload,andrunsona...
(Date:11/25/2009)...USNewswire/--AnarticlebyJanetWoodcock,M.D.,directo...ed"ADifficultBalance-PainManagement,DrugSafety,and...dJournalofMedicine. ,, (Logo: http://www.newsco...rticle,WoodcockdiscussesFDAeffortstostrikeabalance...anagingtherisksposedbyvariousanalgesics.Asexamples...
(Date:11/25/2009)...Business, and Press Join Effort to Educate ,,...- Once again, the National Bipolar Foundation and ...ndorsing their "Safe ,til Stable" program, which i... care measure for bipolar disorder. Today, the Nat...f endorsement via Federal Express Priority Mail fr...
Breaking Medicine News(10 mins):Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 4
...mon problem among children and adolescents. Most o...e on drugs, are more interested in dragging them f... little // focus, which is given to identify the v...el bad about yourself following a specific event. ...
...he care of his patients that he loses his own heal...oing so. A recent study has reported poor mental h... the UK, supporting the above-mentioned statement.... radiology, surgical oncology, clinical oncology, ...
... that abdominal exercise alone is the best way to ...that combining dieting and plenty of cardiovascula...ith the usual abdominal workouts is the best way t...ion notwithstanding, there is no way to "spot-redu...
... Biocon to colloborate with Nobex Corporation of U...r cardiovascular diseases. The spokesperson of Bio... research collaboration // on Tuesday for developm...ion capabilities of Biocon with the proprietary or...
... found that the there is a marked difference betwe...hetamine use in onset, pattern and duration of the...ive, or self-reported, responses to cocaine peak a...cline more rapidly. The study was published i...
... to measure the iron deficiency in infants earlier...of the Journal of the American Medical Association...ly 10 percent // of children of one to two years o...rogresses to anemia (clinically identified as a lo...
Other Medicine News:Health News:Effective Treatment Of Drug Abuse Dependent On Feelings Of Shame Or Guilt 2Health News:New Blood Test To Detect Iron Level In Infants 2
Cushing Burr
Doro J-Arm Retractor System
Molt 9
Langenbeck Periosteal Elevators
Medicine Products: